A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation. In a clinical trial, symptoms fell by 52% and 68% of patients reached remission. Researchers said the approach could guide more precise treatments for other mental health conditions.
Why it matters: People with post-traumatic stress, including veterans, could gain a faster and more targeted treatment option.
A newly FDA-cleared PTSD treatment using personalized brain mapping and magnetic stimulation reduced symptoms by 52% and achieved 68% remission in a clinical trial. Researchers said it could lead to more precise treatments for other mental health conditions.
Why it matters: It offers a new cleared option for a condition that often resists existing treatments.